Ethicon Endo-Surgery, Inc. Sustainability Profile
Ethicon Endo-Surgery, Inc., a subsidiary of Johnson & Johnson, is a leading player in the medical device industry, specialising in surgical products and solutions. Headquartered in the United States, the company operates extensively across North America, Europe, and Asia, providing innovative technologies that enhance surgical procedures. Founded in 1991, Ethicon has achieved significant milestones, including advancements in minimally invasive surgery. The company is renowned for its core offerings, which include advanced stapling devices, energy products, and surgical sutures, all designed to improve patient outcomes and streamline surgical workflows. Ethicon's commitment to innovation has solidified its market position, making it a trusted name among healthcare professionals. With a focus on quality and safety, Ethicon Endo-Surgery continues to lead the way in transforming surgical practices worldwide.
DitchCarbon Score
How does Ethicon Endo-Surgery, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ethicon Endo-Surgery, Inc.'s score of 78 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ethicon Endo-Surgery, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Johnson & Johnson, and as such, it inherits emissions data and climate commitments from its parent organisation. Ethicon Endo-Surgery is aligned with several climate initiatives cascaded from Johnson & Johnson, including the Science Based Targets initiative (SBTi), CDP, and RE100. However, specific reduction targets or achievements for Ethicon Endo-Surgery are not detailed in the available information. As part of its commitment to sustainability, Ethicon Endo-Surgery is expected to adhere to the broader climate strategies and targets set by Johnson & Johnson, which focus on reducing greenhouse gas emissions across all scopes. This includes efforts to enhance energy efficiency and transition to renewable energy sources, although specific metrics or targets for Ethicon Endo-Surgery are not provided. In summary, while Ethicon Endo-Surgery, Inc. does not present its own emissions data or reduction targets, it is part of a corporate family that is actively engaged in climate commitments through Johnson & Johnson's established initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 1990 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 308,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 751,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 00,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Ethicon Endo-Surgery, Inc.'s Industry?
How Carbon Intensive is Ethicon Endo-Surgery, Inc.'s Location?
Ethicon Endo-Surgery, Inc.'s Scope 3 Categories Breakdown
Ethicon Endo-Surgery, Inc.'s Scope 3 emissions, which decreased by 2% last year and increased significantly since 2011, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 72% of Scope 3 emissions.
Top Scope 3 Categories
Ethicon Endo-Surgery, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ethicon Endo-Surgery, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
